Use of acetylcholine esterase inhibitors in the treatment of peripheral nervous system diseases
We consider the possibility of acetylcholinesterase inhibitors use, primarily ipidakrine (Aksamon), in the treatment of diseases of the peripheral nervous system (various mono- or polyneuropathy, neuralgia, etc.). It is emphasized that the ipidakrine inclusion in the remedial measure complex leads to increase of treatment efficacy, reduction of recovery period, and is not accompanied by the risk of development of muscle contractures in patients with injuries of peripheral nerves. In addition to the positive impact on the restoration of impulse conduction in peripheral nerves and the reinnervation process, ipidakrin has analgesic effect. The good drug tolerability enables to recommend it to a wide range of patients, including elderly with concomitant diseases.

Keywords: neuropathies, peripheral nervous system diseases, ipidakrin, acetylcholinesterase inhibitors